- $69.47m
- $59.61m
- $10.89m
- 98
- 48
- 80
- 89
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.73 | ||
| Price to Tang. Book | 5.73 | ||
| Price to Free Cashflow | 17.32 | ||
| Price to Sales | 5.64 | ||
| EV to EBITDA | 15.86 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 30.15% | ||
| Return on Equity | 28.72% | ||
| Operating Margin | 29.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 13.6 | 10.99 | 13.93 | 12.7 | 10.89 | n/a | n/a | -4.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +9.15 | -30.59 | +40.96 | -44.84 | +0.46 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.
Directors
- Kenneth Globus CHM (69)
- Andrea Young CFO (52)
- Peter Hiltunen SVP (62)
- Donna Vigilante VPR (41)
- Andrew Boccone IND (75)
- Arthur Dresner IND (79)
- Lawrence Maietta IND (63)
- S. Ari Papoulias IND (67)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- April 22nd, 1987
- Public Since
- March 17th, 1980
- No. of Shareholders
- 355
- No. of Employees
- 25
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 4,594,319
- Address
- 230 Marcus Blvd, HAUPPAUGE, 11788-3731
- Web
- https://u-g.com/
- Phone
- +1 6312730900
- Auditors
- Grassi & Co., CPAs, P.C.
Upcoming Events for UG
Q4 2024 United-Guardian Inc Earnings Release
Similar to UG
111
NASDAQ Global Market
ADMA Biologics
NASDAQ Global Market
ANI Pharmaceuticals
NASDAQ Global Market
Aquestive Therapeutics
NASDAQ Global Market
Avadel Pharmaceuticals
NASDAQ Global Market
FAQ
What is the United-Guardian share price?
As of Today at 23:53 UTC, shares in United-Guardian are trading at $15.12. This share price information is delayed by 15 minutes.
How has the United-Guardian share price performed this year?
Shares in United-Guardian last closed at $15.12 and the price had moved by +102.95% over the past 365 days. In terms of relative price strength the United-Guardian share price has outperformed the S&P500 Index by +51.66% over the past year.
What are the analyst and broker recommendations for United-Guardian?
There is no consensus recommendation for this security.
Find out moreWhat is the United-Guardian dividend yield?
The United-Guardian dividend yield is 3.97% based on the trailing twelve month period.
Does United-Guardian pay a dividend?
Last year, United-Guardian paid a total dividend of $0.60, and it currently has a trailing dividend yield of 3.97%. We do not have any data on when United-Guardian is to next pay dividends.
When does United-Guardian next pay dividends?
We do not have data on when United-Guardian is to next pay dividends. The historic dividend yield on United-Guardian shares is currently 3.97%.
How do I buy United-Guardian shares?
To buy shares in United-Guardian you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of United-Guardian?
As of the previous close price of $15.12, shares in United-Guardian had a market capitalisation of $69.47m.
Where are United-Guardian shares listed?
Here are the trading details for United-Guardian:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: UG
What kind of share is United-Guardian?
Based on an overall assessment of its quality, value and momentum United-Guardian is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a United-Guardian share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the United-Guardian share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like United-Guardian. Over the past six months, its share price has outperformed the S&P500 Index by +80.62%.
As of the last closing price of $15.12, shares in United-Guardian were trading +58.02% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the United-Guardian PE Ratio?
The United-Guardian PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $15.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of United-Guardian?
United-Guardian's management team is headed by:
- Kenneth Globus - CHM
- Andrea Young - CFO
- Peter Hiltunen - SVP
- Donna Vigilante - VPR
- Andrew Boccone - IND
- Arthur Dresner - IND
- Lawrence Maietta - IND
- S. Ari Papoulias - IND